Global /United States /Healthcare /Medical Devices /WST
chevron_leftBack
West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc.

WST
NYSE: WST Delayed
295.36USD 1.2%
As of 10 July 2026, West Pharmaceutical Services, Inc. has a market cap of $20.87B USD, ranking #1181 globally and #437 in the United States. It ranks #89 in the Healthcare sector, and #24 in the Medical Devices industry.
Global Rank
1181
1d: +1
1w: +4
1m: -
Country Rank
437
1d: 0
1w: +7
1m: -
Sector Rank
89
1d: 0
1w: +1
1m: -
Industry Rank
24
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$20.87BUSD
Enterprise Value
$20.56BUSD
Revenue (TTM)
$3.22BUSD
EBITDA (TTM)
$869.9MUSD
Net Income (TTM)
$542.7MUSD
EBITDA Margin
27%
Profit Margin
17%
PE Ratio
39.5
Forward PE
33.9
PS Ratio
6.4
PB Ratio
6.9
EV/EBITDA
23.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Eric Green open_in_new
Employees
10,800
Founded
1923
Website
westpharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.2% 7.6% 21% 25% 4.2% 37%

News

Loading...

WST Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
WST
West Pharmaceutical Services Inc
ISIN: US9553061055
Shares Out.:
70.648M1 Shares Float: 70.196M2
TV:
SA:
YF:
WST
GF:
NQ:
WST
BA:
WST
MS:
295.36 USD
London Stock Exchange
MIC: XLON
0ADY
West Pharmaceutical Services Inc
ISIN: US9553061055
TV:
SA:
YF:
GF:
BA:
MS:
278.00 USD
Borsa Italiana
MIC: XMIL
1WST
West Pharmaceutical Services Inc
ISIN: US9553061055
TV:
SA:
YF:
GF:
BA:
MS:
311.00 EUR
Show all 6 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
730%
25.8
$160.73B
670%
56.7
$159.07B
662%
25.6
DHR
$126.55B
506%
34.7
SYK
$120.69B
478%
38.3
$84.93B
307%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
388%
22.2
$96.34B
84.32B EUR
362%
36.7
7741
$60.56B
9.83T JPY
190%
40.0
$44.95B
39.34B EUR
115%
18.7
ALC
$35.9B
28.99B CHF
72%
37.9
$29.98B
203.66B CNY
44%
26.0
chevron_leftBack